Literature DB >> 23935098

Agonist-dependent endocytosis of γ-aminobutyric acid type A (GABAA) receptors revealed by a γ2(R43Q) epilepsy mutation.

Severine Chaumont1, Caroline André, David Perrais, Eric Boué-Grabot, Antoine Taly, Maurice Garret.   

Abstract

GABA-gated chloride channels (GABAARs) trafficking is involved in the regulation of fast inhibitory transmission. Here, we took advantage of a γ2(R43Q) subunit mutation linked to epilepsy in humans that considerably reduces the number of GABAARs on the cell surface to better understand the trafficking of GABAARs. Using recombinant expression in cultured rat hippocampal neurons and COS-7 cells, we showed that receptors containing γ2(R43Q) were addressed to the cell membrane but underwent clathrin-mediated dynamin-dependent endocytosis. The γ2(R43Q)-dependent endocytosis was reduced by GABAAR antagonists. These data, in addition to a new homology model, suggested that a conformational change in the extracellular domain of γ2(R43Q)-containing GABAARs increased their internalization. This led us to show that endogenous and recombinant wild-type GABAAR endocytosis in both cultured neurons and COS-7 cells can be amplified by their agonists. These findings revealed not only a direct relationship between endocytosis of GABAARs and a genetic neurological disorder but also that trafficking of these receptors can be modulated by their agonist.

Entities:  

Keywords:  GABA Receptors; Neurobiology; Neurological Diseases; Receptor Endocytosis; Trafficking

Mesh:

Substances:

Year:  2013        PMID: 23935098      PMCID: PMC3784734          DOI: 10.1074/jbc.M113.470807

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  76 in total

1.  T-Coffee: A novel method for fast and accurate multiple sequence alignment.

Authors:  C Notredame; D G Higgins; J Heringa
Journal:  J Mol Biol       Date:  2000-09-08       Impact factor: 5.469

2.  Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus.

Authors:  David E Naylor; Hantao Liu; Claude G Wasterlain
Journal:  J Neurosci       Date:  2005-08-24       Impact factor: 6.167

Review 3.  Binding, activation and modulation of Cys-loop receptors.

Authors:  Paul S Miller; Trevor G Smart
Journal:  Trends Pharmacol Sci       Date:  2010-01-25       Impact factor: 14.819

4.  Rapid use-dependent down-regulation of gamma-aminobutyric acid type A receptors in rat mesencephalic trigeminal neurons.

Authors:  Mitsuru Saito; Hiroki Toyoda; Hajime Sato; Hisayoshi Ishii; Youngnam Kang
Journal:  J Neurosci Res       Date:  2009-11-01       Impact factor: 4.164

Review 5.  GABAA receptor trafficking-mediated plasticity of inhibitory synapses.

Authors:  Bernhard Luscher; Thomas Fuchs; Casey L Kilpatrick
Journal:  Neuron       Date:  2011-05-12       Impact factor: 17.173

Review 6.  Regulation of GABA(A) receptor subunit expression by pharmacological agents.

Authors:  Mikko Uusi-Oukari; Esa R Korpi
Journal:  Pharmacol Rev       Date:  2010-02-01       Impact factor: 25.468

7.  Benzodiazepine treatment induces subtype-specific changes in GABA(A) receptor trafficking and decreases synaptic inhibition.

Authors:  Tija C Jacob; Guido Michels; Liliya Silayeva; Julia Haydon; Francesca Succol; Stephen J Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-22       Impact factor: 11.205

8.  Ethanol promotes clathrin adaptor-mediated endocytosis via the intracellular domain of δ-containing GABAA receptors.

Authors:  Claudia Gonzalez; Stephen J Moss; Richard W Olsen
Journal:  J Neurosci       Date:  2012-12-05       Impact factor: 6.167

9.  Protein interactions involving the gamma2 large cytoplasmic loop of GABA(A) receptors modulate conductance.

Authors:  Andrea B Everitt; Victoria A L Seymour; John Curmi; Derek R Laver; Peter W Gage; M Louise Tierney
Journal:  FASEB J       Date:  2009-08-24       Impact factor: 5.191

10.  Regulation of synaptic inhibition by phospho-dependent binding of the AP2 complex to a YECL motif in the GABAA receptor gamma2 subunit.

Authors:  Josef T Kittler; Guojun Chen; Viktoria Kukhtina; Ardeschir Vahedi-Faridi; Zhenglin Gu; Verena Tretter; Katharine R Smith; Kristina McAinsh; I Lorena Arancibia-Carcamo; Wolfram Saenger; Volker Haucke; Zhen Yan; Stephen J Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-27       Impact factor: 11.205

View more
  13 in total

1.  Three epilepsy-associated GABRG2 missense mutations at the γ+/β- interface disrupt GABAA receptor assembly and trafficking by similar mechanisms but to different extents.

Authors:  Xuan Huang; Ciria C Hernandez; Ningning Hu; Robert L Macdonald
Journal:  Neurobiol Dis       Date:  2014-05-04       Impact factor: 5.996

Review 2.  Genetic and Molecular Regulation of Extrasynaptic GABA-A Receptors in the Brain: Therapeutic Insights for Epilepsy.

Authors:  Shu-Hui Chuang; Doodipala Samba Reddy
Journal:  J Pharmacol Exp Ther       Date:  2017-11-15       Impact factor: 4.030

3.  A versatile optical tool for studying synaptic GABAA receptor trafficking.

Authors:  Joshua M Lorenz-Guertin; Madeleine R Wilcox; Ming Zhang; Mads B Larsen; Jyotsna Pilli; Brigitte F Schmidt; Marcel P Bruchez; Jon W Johnson; Alan S Waggoner; Simon C Watkins; Tija C Jacob
Journal:  J Cell Sci       Date:  2017-10-12       Impact factor: 5.285

4.  Synthesis of Phthaladyn-29 and Naphthalimide-10, GTP Site Directed Dynamin GTPase Inhibitors.

Authors:  Cecilia C Russell; Kate L Prichard; Nicholas S O'Brien; Adam McCluskey; Phillip J Robinson; Jennifer R Baker
Journal:  Methods Mol Biol       Date:  2022

5.  GABA transporters regulate tonic and synaptic GABAA receptor-mediated currents in the suprachiasmatic nucleus neurons.

Authors:  Michael Moldavan; Olga Cravetchi; Charles N Allen
Journal:  J Neurophysiol       Date:  2017-08-30       Impact factor: 2.714

6.  Long distance effect on ligand-gated ion channels extracellular domain may affect interactions with the intracellular machinery.

Authors:  Maurice Garret; Eric Boué-Grabot; Antoine Taly
Journal:  Commun Integr Biol       Date:  2014-02-06

7.  Inhibition of AAK1 Kinase as a Novel Therapeutic Approach to Treat Neuropathic Pain.

Authors:  Walter Kostich; Brian D Hamman; Yu-Wen Li; Sreenivasulu Naidu; Kumaran Dandapani; Jianlin Feng; Amy Easton; Clotilde Bourin; Kevin Baker; Jason Allen; Katerina Savelieva; Justin V Louis; Manoj Dokania; Saravanan Elavazhagan; Pradeep Vattikundala; Vivek Sharma; Manish Lal Das; Ganesh Shankar; Anoop Kumar; Vinay K Holenarsipur; Michael Gulianello; Ted Molski; Jeffrey M Brown; Martin Lewis; Yanling Huang; Yifeng Lu; Rick Pieschl; Kevin O'Malley; Jonathan Lippy; Amr Nouraldeen; Thomas H Lanthorn; Guilan Ye; Alan Wilson; Anand Balakrishnan; Rex Denton; James E Grace; Kimberley A Lentz; Kenneth S Santone; Yingzhi Bi; Alan Main; Jon Swaffield; Ken Carson; Sandhya Mandlekar; Reeba K Vikramadithyan; Susheel J Nara; Carolyn Dzierba; Joanne Bronson; John E Macor; Robert Zaczek; Ryan Westphal; Laszlo Kiss; Linda Bristow; Charles M Conway; Brian Zambrowicz; Charles F Albright
Journal:  J Pharmacol Exp Ther       Date:  2016-07-13       Impact factor: 4.030

8.  Pilocarpine-induced seizures trigger differential regulation of microRNA-stability related genes in rat hippocampal neurons.

Authors:  Erika R Kinjo; Guilherme S V Higa; Bianca A Santos; Erica de Sousa; Marcio V Damico; Lais T Walter; Edgard Morya; Angela C Valle; Luiz R G Britto; Alexandre H Kihara
Journal:  Sci Rep       Date:  2016-02-12       Impact factor: 4.379

9.  SAHA (Vorinostat) Corrects Inhibitory Synaptic Deficits Caused by Missense Epilepsy Mutations to the GABAA Receptor γ2 Subunit.

Authors:  Nela Durisic; Angelo Keramidas; Christine L Dixon; Joseph W Lynch
Journal:  Front Mol Neurosci       Date:  2018-03-23       Impact factor: 5.639

10.  Age-Related Changes in Pre- and Postsynaptic Partners of the Cholinergic C-Boutons in Wild-Type and SOD1G93A Lumbar Motoneurons.

Authors:  Léa Milan; Gilles Courtand; Laura Cardoit; Frédérique Masmejean; Grégory Barrière; Jean-René Cazalets; Maurice Garret; Sandrine S Bertrand
Journal:  PLoS One       Date:  2015-08-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.